ORIGINAL ARTICLE

Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy

H-S Wang¹, M-F Kuo², M-L Chou¹, P-C Hung¹, K-L Lin¹, M-Y Hsieh¹, M-Y Chang¹

¹ Division of Pediatric Neurology, Chang Gung Children’s Hospital, and Medical College of Chang Gung University, Taoyuan, Taiwan
² Division of Neurosurgery, Department of Surgery, National Taiwan University Hospital, and National Taiwan University College of Medicine, Taipei, Taiwan

Correspondence to:
Correspondence to:
Dr M-F Kuo
Division of (Pediatric) Neurosurgery, Department of Surgery, National Taiwan University Hospital, 7 Chung-Shan S. Road, Taipei 100, Taiwan; wanghs444{at}cgmh.org.tw

Aim: To study the difference between pyridoxine (PN) and its active form, pyridoxal phosphate, (PLP) in control of idiopathic intractable epilepsy in children.

Methods: Among 574 children with active epilepsy, 94 (aged 8 months to 15 years) were diagnosed with idiopathic intractable epilepsy for more than six months. All received intravenous PLP 10 mg/kg, then 10 mg/kg/day in four divided doses. If seizures recurred within 24 hours, another dose of 40 mg/kg was given, followed by 50 mg/kg/day in four divided doses. For those patients whose seizures were totally controlled, PLP was replaced by the same dose of oral PN. If the seizure recurred, intravenous PLP was infused followed by oral PLP 50 mg/kg/day.

Results: Fifty seven patients had generalised seizures (of whom 13 had infantile spasms) and 37 had focal seizure. Eleven had dramatic and sustained responses to PLP; of these, five also responded to PN. Within six months of treatment with PLP or PN, five of the 11 patients were seizure free and had their previous antiepileptic medicine tapered off gradually. Two were controlled with pyridoxine and the other three needed PLP to maintain seizure freedom. The remaining six responders needed PLP exclusively for seizure control. Six of the 11 responders to PLP had infantile spasms (46%); four of them needed PLP exclusively. The other five responders were in the remaining 81 patients with other seizure type.

Conclusions: PLP could replace PN in the treatment of intractable childhood epilepsy, particularly in the treatment of infantile spasms.

Abbreviations: AED, antiepileptic drug; EEG, electroencephalography; GABA, gamma-aminobutyric acid; PDE, pyridoxine dependent epilepsy; PLP, pyridoxal phosphate; PN, pyridoxine

Keywords: epilepsy; intractable epilepsy; pyridoxal phosphate; pyridoxine; vitamin B6

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Pyridoxine or pyridoxal phosphate for intractable seizures?

P Baxter
Arch. Dis. Child. 2005 90: 441-442. [Extract] [Full Text]

This article has been cited by other articles:

• Bagci, S, Zschocke, J, Hoffmann, G F, Bast, T, Klepper, J, Muller, A, Heep, A, Bartmann, P, Franz, A R (2009). Pyridoxal phosphate-dependent neonatal epileptic encephalopathy. BMJ Case Reports 2009: bcr1120081247-bcr1120081247 [Abstract] [Full Text]  
• Bagci, S, Zschocke, J, Hoffmann, G F, Bast, T, Klepper, J, Muller, A, Heep, A, Bartmann, P, Franz, A R (2008). Pyridoxal phosphate-dependent neonatal epileptic encephalopathy. Arch. Dis. Child. Fetal Neonatal Ed. 93: F151-F152 [Abstract] [Full Text]  
• Baxter, P (2005). Pyridoxine or pyridoxal phosphate for intractable seizures?. Arch. Dis. Child. 90: 441-442 [Full Text]